BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 20420183)

  • 1. [Lambert-Eaton myasthenic syndrome (LEMS)].
    Suzuki S
    Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H; Shiraishi H; Motomura M
    Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lambert-Eaton Myasthenic Syndrome].
    Matsuo H
    Brain Nerve; 2024 May; 76(5):630-634. PubMed ID: 38741506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
    Okada A; Koike H; Nakamura T; Motomura M; Sobue G
    Neuromuscul Disord; 2015 Jan; 25(1):70-2. PubMed ID: 25444432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
    Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
    Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dosage and specificity of anti-calcium channel antibodies in Lambert-Eaton myasthenic syndrome].
    Martin-Moutot N; de Haro L; Seagar M
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S28-34. PubMed ID: 15269657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lambert-Eaton myasthenic syndrome, an immune pathology of neuromuscular junctions].
    Honnorat J
    Bull Acad Natl Med; 2014 Feb; 198(2):243-54; discussion 255. PubMed ID: 26263702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
    Titulaer MJ; Lang B; Verschuuren JJ
    Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M; Odaka M; Nakamura T; Hirata K
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Seronegative nonparaneoplastic Lambert-Eaton myasthenic syndrome].
    Sanadze AG; Sidnev DV; Tumurov DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):77-80. PubMed ID: 28638036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lambert-Eaton myasthenic syndrome as an autoimmune calcium-channelopathy.
    Takamori M; Maruta T; Komai K
    Neurosci Res; 2000 Mar; 36(3):183-91. PubMed ID: 10683522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lambert-Eaton myasthenic syndrome in childhood.
    Kostera-Pruszczyk A; Ryniewicz B; Rowinska-Marcinska K; Dutkiewicz M; Kamińska A
    Eur J Paediatr Neurol; 2009 Mar; 13(2):194-6. PubMed ID: 18585938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paraneoplastic Cerebellar Degeneration with Lambert-Eaton Myasthenic Syndrome: A Report of an Effectively Treated Case and Systematic Review of Japanese Cases].
    Kitanosono H; Motomura M; Tomita H; Iwanaga H; Iwanaga N; Irioka T; Shiraishi H; Tsujino A
    Brain Nerve; 2019 Feb; 71(2):167-174. PubMed ID: 30718446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lambert-Eaton myasthenic syndrome].
    Motomura M; Fukuda T
    Brain Nerve; 2011 Jul; 63(7):745-54. PubMed ID: 21747145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
    Takamori M; Komai K; Iwasa K
    Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Case of anti P/Q type VGCC antibody positive small lung cell carcinoma that occured with subacute cerebellar degeneration, Lambert-Eaton myasthenic syndrome, and brainstem encephalitis].
    Nagayama S; Koike F; Sakai T; Antoku Y; Yukitake M; Kuroda Y
    Brain Nerve; 2008 Dec; 60(12):1470-4. PubMed ID: 19110759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.